Psychemedics Revenue 2010-2024 | PMD

Psychemedics revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Psychemedics Annual Revenue
(Millions of US $)
2023 $22
2022 $25
2021 $25
2020 $21
2019 $38
2018 $43
2017 $40
2016 $39
2015 $27
2014 $29
2013 $27
2012 $25
2011 $24
2010 $20
2009 $17
Psychemedics Quarterly Revenue
(Millions of US $)
2024-09-30 $5
2024-06-30 $5
2024-03-31 $5
2023-12-31 $5
2023-09-30 $6
2023-06-30 $6
2023-03-31 $6
2022-12-31 $6
2022-09-30 $7
2022-06-30 $7
2022-03-31 $7
2021-12-31 $6
2021-09-30 $7
2021-06-30 $6
2021-03-31 $6
2020-12-31 $5
2020-09-30 $5
2020-06-30 $3
2020-03-31 $8
2019-12-31 $9
2019-09-30 $10
2019-06-30 $9
2019-03-31 $10
2018-12-31 $10
2018-09-30 $11
2018-06-30 $11
2018-03-31 $11
2017-12-31 $10
2017-09-30 $10
2017-06-30 $10
2017-03-31 $10
2016-12-31 $11
2016-09-30 $12
2016-06-30 $10
2016-03-31 $7
2015-12-31 $6
2015-09-30 $7
2015-06-30 $7
2015-03-31 $7
2014-12-31 $7
2014-09-30 $8
2014-06-30 $8
2014-03-31 $7
2013-12-31 $6
2013-09-30 $7
2013-06-30 $7
2013-03-31 $6
2012-12-31 $6
2012-09-30 $6
2012-06-30 $7
2012-03-31 $6
2011-12-31 $6
2011-09-30 $6
2011-06-30 $6
2011-03-31 $6
2010-12-31 $5
2010-09-30 $5
2010-06-30 $5
2010-03-31 $4
2009-12-31 $4
2009-09-30 $5
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00